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Abstract
Ischemic heart disease is a leading cause of death worldwide. Osteopontin
(OPN), a cell-secreted extracellular matrix protein, is suggested to play a
cardioprotective role in mouse models of ischemic heart disease. The objective of this
study was to examine the role of OPN in modulation of systolic and diastolic functional
parameters of the heart following mouse ischemia/reperfusion (I/R) injury. For this, wildtype (WT) and OPN-knockout (KO) mice aged approximately 4 months were subjected
to cardiac ischemia for 45 minutes by the ligation of the left anterior descending
coronary artery (LAD) followed by reperfusion of LAD by snipping the ligature. Heart
function was measured using echocardiography at baseline, 1, 3, 7, 14, and 27 days
post-I/R injury. M-mode echocardiographic images were used to calculate % fractional
shortening [%FS], % ejection fraction [%EF], end-systolic volume [ESV], and enddiastolic volume [EDV], while pulsed wave Doppler images were used to measure aortic
ejection time [AET], isovolumic relaxation time [IVRT], and total systolic time [TST].
Velocity of circumferential fiber shortening (Vcf) was calculated using FS and AET. I/R
injury significantly decreased %EF and %FS in both WT and KO groups at all time
points (1, 3, 7, 14, and 27 days post-I/R) versus the baseline. However, the decrease in
% EF and %FS was significantly greater in KO-I/R group versus WT-I/R at 3, 7, 14 and
27 days post-I/R. I/R-mediated increase in ESV and EDV were significantly greater in
KO-MI group versus WT-MI 3 day post-I/R. AET was significantly higher in WT-I/R
group 27 days post-I/R versus baseline. However, AET was significantly lower in KO-I/R
group 3 and 27 days post-I/R versus WT-I/R. IVRT was significantly higher in KO-I/R
group 27 days post-I/R vs baseline. However, IVRT was significantly lower in KO-I/R
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group 1 day post-I/R vs WT-I/R. TST remained unchanged in WT and KO groups postI/R versus their respective baseline groups. However, TST was significantly lower in
KO-I/R group versus WT-I/R at 3 days post-I/R. Vcf was significantly higher at basal
levels in the KO versus WT mice. I/R injury decreased Vcf in both groups versus their
baseline at all time-points. These data provide evidence that lack of OPN deteriorates
systolic and diastolic functional parameters of the heart following I/R injury, suggesting a
cardioprotective role of OPN in myocardial remodeling post-IR.
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Introduction
Heart Disease
Heart disease is a leading cause of death in the United States, responsible for
approximately one in four deaths every year1. Over half of these deaths yearly are
attributed to coronary heart disease, which entails a buildup of plaque along the walls of
the coronary arteries causing narrowing and hardening of the arteries thereby partially
or completely blocking the blood supply to the heart. This buildup can be caused by a
variety of factors. Poor lifestyle habits, such as poor diet, lack of exercise, and smoking
are described as major factors contributing to coronary heart disease.
The aforementioned occlusion of coronary arteries often leads to an insufficient
supply of blood to the heart, known as ischemia. Ischemia results in damage to the
heart muscle commonly referred to as heart attack or myocardial infarction (MI).
According to the Centers for Disease Control and Prevention, one person suffers from a
heart attack every 40 seconds, which amounts to approximately 790,000 incidents per
year1.
Myocardial Ischemia/Reperfusion Injury
The blockage of oxygen and nutrients during ischemia results in cardiac muscle
damage and death. Following an ischemic event, early reperfusion of blood flow to the
area of the infarct is the current standard of therapy to reduce infarct size, minimize
myocardial damage, and preserve heart function2. However, the process of reperfusion,
in some cases, lead to further damage to the cardiac muscle. The integrated damage
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from the ischemia and reperfusion to the heart is known as myocardial ischemiareperfusion (I/R) injury.
The complex pathophysiology of myocardial I/R injury results in chronic heart
failure. During an ischemic event, blockage of the artery deprives the heart of oxygen
and nutrients, resulting in an abrupt halt of oxidative phosphorylation and leading to
depolarization of the mitochondrial membranes, depletion of ATP, and inhibition of the
heart’s contractile function2. This, in turn, forces the cell to switch to anaerobic
respiration, resulting in lactate production and a decrease in intracellular pH. The
increased acidity results in an overload of Na+ and Ca2+ in the cardiac cells and
induces myocardial contractile dysfunction2.
The damaging effects of reperfusion include reactivation of electron transport
chain generating reactive oxygen species (ROS), an increase in oxidative stress,
inflammation, and intracellular Ca2+ overload, leading ultimately to myocytes apoptosis,
necrosis, hypertrophy and myocardial fibrosis3,4. Myocytes are vital for heart function, as
they are the primary cells responsible for the rhythmic contraction and relaxation, and
proper functioning of the heart. Importantly, myocytes are terminally differentiated and
non-regenerative cells, therefore new myocytes may never grow to replace myocytes
that have been lost from an injury5. This amplifies the severity of the myocardial I/R
injury.
Additionally, increased levels of ROS impact different proteins involved in the
excitation-contraction coupling mechanism, such as the sarcoplasmic reticulum Ca2+
release channel4. It is suggested that increased oxidative stress plays a primary role in
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diminishing the systolic and diastolic functions of the heart, and contributing to heart
failure following an I/R injury4.
Systolic and Diastolic Functional Parameters of the Heart
The cardiac cycle consists of two phases: systole and diastole. Systole occurs
during the period of contraction when the heart is pushing blood out of its chambers,
followed by diastole, or the relaxation of the heart as it refills with blood. Left ventricular
systolic and diastolic dysfunction are primary indicators of coronary heart disease6.
Therefore, several measurements can be analyzed to detect myocardial dysfunction.
Systolic heart function can be measured using calculations such as % fractional
shortening (%FS) and % ejection fraction (%EF). %FS is another term for the
percentage of the size reduction of the left ventricle that occurs by the end of systole7.
%EF denotes the amount of blood ejected from the left ventricle during a period of
systole8. These calculations are a measure of the contractility of the heart’s muscle.
Diastolic function of the heart can be measured using calculations such as isovolumic
relaxation time (IVRT) and E/A wave ratio, where E wave represents the peak velocity
of early left ventricular filling and A wave represents the peak velocity of late left
ventricular filling.
Other parameters which are also used to assess heart function include
measurement of end diastolic volume (EDV), end systolic volume (ESV), aortic ejection
time (AET), and total systolic time (TST). EDV refers to the volume of blood in the
ventricles before the heart contracts, while ESV is the volume of the blood at the end of
contraction9. AET measures the rate at which the left ventricle is pumping out blood10.
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IVRT is the time from aortic valve closure to the opening of the mitral valve11. In other
words, AET and IVRT describe the periods of contraction and relaxation of the heart
muscle. TST is the total amount of time from the beginning of heart muscle contraction
to the end of relaxation. Velocity of circumferential fiber shortening (Vcf) is a measure of
left ventricular mechanical function by examining the degree of fiber shortening and the
duration of ejection12.
Osteopontin
Osteopontin (OPN), also referred as cytokine Eta-1, is a cell-secreted
extracellular matrix protein5. It was first identified in 1979 as being associated with
malignant transformation but has since been shown to play a role in a range of
biological processes. OPN is located on human chromosome 4q13 and has 314 amino
acid residues, exhibiting high homology among many species such as humans, rats,
and mice13. Due to the presence of RGD (Arg-Gly-Asp) amino acid residue, OPN is
shown to interact with a variety of cell surface integrin receptors family. In cardiac
myocytes, OPN is suggested to interact with a variant of hyaluronan receptor, CD4414.
OPN is described as a protein with diverse biological functions such as bone
resorption, immune cell activation, extracellular matrix remodeling, and
inflammation13,15. The heart expresses low levels of OPN under basal conditions.
Myocytes, fibroblasts and endothelial cells of the heart are shown to express OPN. A
variety of stimuli such as angiotensin II, glucocorticoid hormone, cytokines, endothelin,
norepinephrine are suggested to increase OPN expression in the heart and cardiac
cells5. In the heart, increased OPN expression associates with the development of heart
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failure16. Cardiac myocytes are identified as a source of OPN in models of myocardial
hypertrophy5. OPN expression increases in both infarct and non-infarct regions of the
heart post-MI in animal models17, and in cardiac myocytes of patients with dilated
cardiomyopathy5,14.
A cardioprotective role of OPN has been demonstrated in a non-reperfused
mouse model, MI, of myocardial remodeling. Mice lacking OPN exhibited exaggerated
left ventricular chamber dilation following MI compared to wild-type mice due to
increased expansion of the infarcted and remote myocardium17. OPN knock-out mice
also exhibited decreased collagen accumulation and fibrosis deposition in the heart 28
days post-MI17. In a mouse model of repetitive myocardial I/R injury over a period of 7
days, OPN is shown to modulate contractile elements, antioxidative mediators, and
inflammatory response18. These studies suggest a cardioprotective role of increased
OPN expression during the development of ischemic heart disease. However, the role
of OPN in systolic and diastolic functional parameters of the heart following an I/R injury
remains to be fully explored.
Specific Aim
The objective of this study was to determine the role of OPN in the modulation of
systolic and diastolic functional parameters of the heart following a myocardial
ischemia/reperfusion injury in a time-dependent manner. It was hypothesized that lack
of OPN would decrease the functional parameters of the heart following
ischemia/reperfusion injury.
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Materials and Methods
Animal Care
This study was conducted in accordance with the Guide for the Care and Use of
Laboratory Animals published by the U.S. National Institutes of Health (NIH Publication
No. 85-23, revised 1996). The animal protocols were approved by the East Tennessee
State University Committee on Animal Care. Buprenorphine was administered
subcutaneously 30 min prior to the surgery and once per day for 2 days after surgery to
relieve pain. Mice were anesthetized using a mixture of 2.5% isoflurane and oxygen at a
flow rate of 0.5 L/min. The study used both male and female mice, aged approximately
4 months, with 129X black Swiss hybrid background. After genotyping, wild-type (WT)
mice and OPN-knockout (KO) mice were bred and maintained as separate colonies.
Myocardial Ischemia/Reperfusion (I/R) Injury
Myocardial I/R surgery was performed in WT and KO mice as described
previously19. Briefly, mice were anesthetized using a mixture of 2.5% isoflurane and 0.5
L/min of oxygen and ventilated using a Harvard Apparatus rodent ventilator. Body
temperature was maintained at approximately 37°C during surgery using a heating pad.
The heart was exposed via a left thoracotomy. Cardiac ischemia was induced by
ligating the left anterior descending artery (LAD) for 45 minutes using a 7-0 braided silk
suture, which was tied around a piece of polypropylene tubing to allow easy reperfusion.
After 45 minutes of ischemia, polypropylene tubing was removed and the ligature was
snipped to allow reperfusion to occur. Ischemia was confirmed by a visible pale coloring
of the heart and ST segment elevation in the EKG. Reperfusion was confirmed by
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restoration of pink color of the heart. Functional parameters were measured using
echocardiographic images at basal levels and 1, 3, 7, 14, and 27 days following I/R
injury.
Echocardiography
Heart function was measured using transthoracic two-dimensional M-mode and
pulsed-wave Doppler echocardiograms obtained using a VEVO 1100 imaging system
(VisualSonics, Fujifilm) equipped with an MS550D 22-55MHz Microscan transducer.
Echocardiography was performed at baseline, 1, 3, 7, 14, and 27 days following I/R
surgery. Mice were anesthetized during echocardiography using a mixture of 2.5%
isoflurane and 0.5 L/min of oxygen, and body temperature was maintained at
approximately 37°C using a heating pad. Heart rate was maintained between 400-500
beats/min. M-mode images were used to measure end-systolic and end-diastolic
diameters, which were then used to calculate %FS, %EF, ESV and EDV as described19
(Fig.1). Pulsed-wave Doppler images were used to measure AET, IVRT, and TST
(Fig.2). Vcf was calculated as a ratio of FS and AET.
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Figure 1. Representative M-mode image depicting left ventricular end diastolic
volume (LVEDD), left ventricular end systolic volume (LVESD) and left ventricular
cavity.

Figure 2. Representative pulsed-wave Doppler image depicting total systolic
time (TST), isovolumic contraction time (IVCT), aortic ejection time (AET), and
isovolumic relaxation time (IVRT).
Statistical Analysis
All data are expressed as mean ± SE. Data were analyzed using the 2-tailed
Student’s t-test. Probability (p) values of <0.05 were considered to be significant.
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Results
Lack of OPN decreases percent fractional shortening (%FS) starting 3 days post-I/R
%FS (a measure of systolic function) is calculated as = (LVEDD-LVESD /
LVEDD) x 100; where LVEDD represents left ventricular end diastolic diameter and
LVESD represents left ventricular end systolic diameter. These parameters were
measured using M-mode images as depicted in Figure 1. Calculation of %FS revealed
no significant difference between the two genotypes (WT and KO) at basal levels
(baseline). I/R injury significantly decreased %FS in both genotypes starting 1 day postI/R, and remained significantly lower in both genotypes versus their baseline throughout
the observation period ($p<0.05 vs baseline; n=7-16; Figure 3). Additionally, %FS was
significantly lower at 14 days post-I/R in WT group versus 3 days post-I/R (#p<0.05 vs 3
days post-I/R; n=7-16; Figure 3). KO-I/R group also exhibited a decline in %FS with
time, and was significantly lower at 7, 14 and 27 days post-I/R versus 3 days post-I/R
(@p<0.05 vs 3 days post-I/R; n=7-16; Figure 3). Interestingly, I/R-mediated decrease in
%FS was significantly lower in KO-I/R group versus the WT-I/R group starting 3 days
post-I/R and remained lower throughout the observation period (*p<0.05 vs WT-I/R;
n=7-16; Figure 3).
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Figure 3. Lack of OPN decreases %FS post-I/R. $p<0.05 vs WT and KO
baseline; #p<0.05 vs 3 days post-I/R (WT group); @p<0.05 vs 3 days post-I/R
(KO group); *p<0.05 KO-IR vs WT-I/R n=7-16.

Lack of OPN increases LV end systolic volume (ESV) starting 1 day post-I/R
ESV is the volume of blood remaining in the left ventricle at the end of systole. It
was calculated using LVESD from M-mode images depicted in Figure 1 using a Fujifilm
software on the VEVO 1100 echocardiographic system. ESV calculations showed no
significant difference between WT and KO mice at baseline. The ESV was significantly
higher at 7, 14, and 27 days post-I/R when compared to the baseline in WT group.
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However, ESV was significantly greater in KO-I/R group 1 day post-I/R, and remained
higher throughout the time course ($p<0.05 vs baseline; n=7-16; Figure 4). In WT-I/R
group, ESV was significantly elevated at 14 and 27 days post-I/R versus 3 days post-I/R
(#p<0.05 vs 3 days post-I/R; n=7-16; Figure 4). In KO-I/R group, ESV was significantly
higher at 14 and 27 days versus 1, 3, and 7 days post-I/R (@p<0.05 vs 1, 3 and 7 days
post-I/R; n=7-16; Figure 4). Notably, there was a significant increase in ESV in KO-I/R
group vs WT-I/R at 3 days post-I/R (*p<0.05 vs WT I/R; n=7-16; Figure 4).

Figure 4. Lack of OPN increases ESV (in µl) starting 1 day post-I/R. $p<0.05 vs
WT and KO baseline; #p<0.05 vs 3 days post-I/R (WT group); @p<0.05 vs 1, 3
and 7 days post-I/R (KO group); *p<0.05 KO-I/R vs WT-I/R; n=7-16.
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Lack of OPN increases end diastolic volume (EDV) 3 days post-I/R
EDV is the volume of blood in the left ventricle right before the heart contracts. It
was calculated using LVESD from M-mode image depicted in Figure 1 using Fujifilm
software on the VEVO 1100. There was no significant difference in EDV between WT
and KO mice at basal levels. I/R led to a significant increase in EDV in both genotypes
14 and 27 days post-I/R versus baseline ($p<0.05 vs baseline; n=7-16; Figure 5).
Additionally, EDV was significantly higher in WT-I/R group at 14 and 27 days post-I/R
versus 1 and 3 days post-I/R (#p<0.05 vs 1 and 3 days post-I/R; n=7-16; Figure 5). In
KO-I/R group, EDV was significantly higher at 14 and 27 post-I/R versus 1, 3, and 7
days post-I/R (@p<0.05 vs 1, 3 and 7 days post-I/R; n=7-16; Figure 5). Interestingly,
there was a significant increase in EDV in KO-I/R group vs WT-I/R at 3 days post-I/R
(*p<0.05 vs WT I/R; n=7-16; Figure 5).
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Figure 5. Lack of OPN increases EDV (in µl) 3 days post-I/R. $p<0.05 vs WT and
KO baseline; #p<0.05 vs 1 and 3 days post-I/R (WT group); @p<0.05 vs 1, 3 and
7 days post-I/R (KO group); *p<0.05 KO-I/R vs WT-I/R; n=7-16.

Lack of OPN decreases percent ejection fraction (%EF) starting 7 days post-I/R
%EF represents the percentage of blood leaving the left ventricle each time it
contracts. It is calculated using ESV and EDV as (EDV-ESV)/EDVx100. Calculation of
%EF revealed no significant difference between WT and KO mice at basal levels. I/R
led to significant decrease in %EF in both genotypes versus their respective baseline
controls starting 1 day post-I/R. %EF remained significantly lower in both I/R groups
versus their baseline throughout the observation period ($p<0.05 vs baseline; n=7-16;
Figure 6). Additionally, %EF was significantly lower WT-I/R group at 14 days post-I/R
versus 3 days post-I/R (#p<0.05 vs 3 days post-I/R; n=7-16; Figure 6). In KO-I/R group,
%EF was significantly lower at 14 and 27 post-I/R versus 3 and 7 days post-I/R
(@p<0.05 vs 3 and 7 days post-I/R; n=7-16; Figure 6). Importantly, I/R injury significantly
decreased %EF in KO-I/R group versus WT-I/R group at 3, 7, 14, and 27 days post-I/R
(*p<0.05 vs WT-I/R; n=7-16; Figure 6).
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Figure 6. Lack of OPN decreases %EF starting 7 day post-I/R. $p<0.05 vs WT
and KO baseline; #p<0.05 vs 3 days post-I/R (WT group); @p<0.05 vs 3 and 7
days post-I/R (KO group); *p<0.05 KO-I/R vs WT-I/R; n=7-16.

Lack of OPN decreases aortic ejection time (AET) 3 and 27 days post-I/R
AET is the time between the opening and closing of the aortic valve. It is
measured using the pulsed-wave Doppler images depicted in Figure 2. No significant
difference in AET was observed at basal levels between the two genotypes. AET was
found to significantly higher in WT-I/R group at 27 days post-I/R versus baseline
($p<0.05 vs baseline; n=6-10), while it remained unchanged in the KO-I/R group versus
19

baseline throughout the observation period. AET was significantly greater in WT-I/R
group at 27 days post-I/R versus 1, 3 and 14 days post-I/R (#p<0.05 vs 1, 3 and 14 days
post-I/R; n=6-10; Figure 7). In KO-I/R group, AET was significantly higher at 7 days
post-I/R versus 1 and 3 days post-I/R (@p<0.05 vs 1 and 3 days post-I/R; n=6-10;
Figure 7). Interestingly, AET was significantly lower in KO-I/R group versus WT-I/R
group at 3 and 27 days post-I/R (*p<0.05 vs WT I/R; n=6-10; Figure 7).

Figure 7. Lack of OPN decreases AET (in ms) 3 and 27 days post-I/R. $p<0.05
vs WT and KO baseline; #p<0.05 vs 1, 3 and 14 days post-I/R (WT group);
@

p<0.05 vs 1 and 3 days post-I/R (KO group); *p<0.05 KO-I/R vs WT-I/R; n=6-

10.
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Lack of OPN decreases isovolumic relaxation time (IVRT) 1 day post-I/R
IVRT, a measure of diastolic function, represents the time interval in the cardiac
cycle from the closing of the aortic valve to the opening of the mitral valve. It is
measured using pulsed-wave Doppler images as depicted in Figure 2. IVRT was not
found to be significantly different between the two genotypes at baseline. I/R injury
significantly increased IVRT in KO group 27 days post-I/R versus baseline ($p<0.05 vs
baseline; n=6-10; Figure 8). Additionally, IVRT was found to be significantly lower at 14
days post-I/R versus 1 day post-I/R in WT group (#p<0.05 vs 1 days post-I/R; n=6-10).
In KO-I/R group, IVRT was significantly higher at 27 days post-I/R versus 1, 3 and 7
days post-I/R (@p<0.05 vs 1, 3 and 7 days post-I/R; n=6-10; Figure 8). Interestingly, I/R
injury resulted in a significant decline in IVRT in KO-I/R group versus WT-I/R group 1
day post-I/R (*p<0.05 vs WT I/R; n=6-10; Figure 8).
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Figure 8. Lack of OPN decreases IVRT (in ms) 1 day post-I/R. $p<0.05 vs WT
and KO baseline; #p<0.05 vs 1 day post-I/R (WT group); @p<0.05 vs 1, 3 and 7
days post-I/R (KO group); *p<0.05 KO-I/R vs WT-I/R; n=6-10.

Lack of OPN decreases total systolic time (TST) 3 days post-I/R
TST represents the time interval from the onset of closing of the mitral valve to
the opening of the mitral valve. It combines IVCT+AET+IVRT, where IVCT (isovolumic
contraction time) is a time interval from the closure of the mitral valve to the opening of
the aortic valve. IVCT is measured using pulsed-wave Doppler images as exhibited in
Figure 2. There was no significant difference in TST between the two genotypes at
basal levels. I/R injury did not result in a significant change at any point in the time
course compared to the baseline in either group. However, TST was significantly lower
in WT-I/R group at 14 days post-I/R versus 7 and 27 days post-I/R (#p<0.05 vs 7 and 27
days post-I/R; n=6-10; Figure 9). In KO-I/R group, TST was significantly lower at 3 days
post-I/R versus 7 and 27 days post I/R (@p<0.05 vs 7 and 27 days post-I/R; n=6-10;
Figure 9). Interestingly, TST was significantly lower in KO-I/R group versus WT-I/R
group 3 days post-I/R. (*p<0.05 vs WT-I/R; n=6-10; Figure 9).
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Figure 9. Lack of OPN decreases TST (in ms) 3 days post-I/R. #p<0.05 vs 7 and
27 days post-I/R (WT group); @p<0.05 vs 7 and 27 days post-I/R (KO group);
*p<0.05 KO-I/R vs WT-I/R; n=6-10.

Lack of OPN differentially affects velocity of circumferential fiber shortening (Vcf)
Vcf is a preload independent measurement of LV systolic function. It is calculated
using M-mode and pulsed-wave Doppler images as (FS/AET) x 1000 in mm/sec.
Calculations are generated using both M-mode and pulsed-wave Doppler images as
shown in Figures 1 and 2. Results revealed that the Vcf is significantly higher in KO
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group when compared to the WT group at basal levels (^p<0.05 vs WT baseline; n=610; Figure 10). I/R injury decreased Vcf in both groups 1 day post-I/R versus their
respective baseline. Vcf was also found to be significantly lower at 27 days post-I/R
versus baseline in WT-I/R group. In KO-I/R group, significant decrease in Vcf versus
baseline was observed throughout the time course ($p<0.05 vs baseline; n=6-10; Figure
10). In addition, Vcf was significantly lower at 14 and 27 days post-I/R when compared
to 3 days post-I/R in KO-I/R group (@p<0.05 vs 3 days; n=6-10; Figure 10).
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Figure 10. Lack of OPN differentially affects Vcf (in mm/sec). ^p<0.05 WT
baseline vs KO baseline; $p<0.05 vs WT and KO baseline; @p<0.05 vs 3 days
post-I/R (KO group). n=6-10.
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Discussion
Previously, a cardioprotective role of OPN has been demonstrated in a nonreperfused MI mouse model, as well as in a mouse model of a repetitive I/R injury over
7 days17,18. This study investigated the role of OPN in systolic and diastolic functional
parameters of the heart following an I/R injury in a time-dependent manner using WT
and OPN-KO mice. The major findings of the study are that lack of OPN – 1) decreases
%FS, %EF, AET, IVRT, and TST; and 2) increases ESV and EDV versus WT mice
post-I/R. In addition, increased Vcf (a systolic index representing how fast the left
ventricle shortens) was observed in mice lacking OPN at basal levels.
Myocardial I/R injury is known to induce systolic and diastolic dysfunction6.
Systolic and diastolic functions are characterized by periods of contraction and
relaxation as blood is being pumped in and out of the heart. M-mode images collected
in this study were used to measure systolic heart function, such as %FS, %EF, ESV,
and EDV. The %FS and %EF both decreased significantly throughout the time course
post-I/R compared to the baseline in both OPN-KO and WT mice. However, the
decrease in %FS and %EF was significantly greater in mice lacking OPN at 3, 7, 14,
and 27 days following I/R injury, indicating that lack of OPN induces greater LV systolic
dysfunction post-I/R. Previous work from our lab has shown that lack of OPN associates
with decreased %FS and %EF 14 days post-MI20. Likewise, a significant decrease in
%FS was observed in mice lacking OPN in a model of repetitive I/R injury 7 days postI/R18. MI model represents a non-reperfused model of myocardial remodeling. The
remodeling of the heart may occur differently between the non-reperfused (MI) versus
the reperfused (I/R) models. Consistent with the non-reperfused MI and repetitive I/R
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models, this study observed that I/R also leads to a significant decline in heart function
as measured by %FS and %EF in mice post-I/R. Interestingly, mice lacking OPN
exhibited greater LV dysfunction starting 3 days post-I/R. Together, these studies
suggest that lack of OPN has an adverse effect on the development of cardiac
dysfunction following a myocardial injury.
Remodeling of the heart following an injury due to MI or I/R induces LV chamber
enlargement. This enlargement associates with increased systolic and diastolic volumes
in the LV. Here, myocardial I/R injury increased both end systolic and diastolic volumes
(ESV and EDV) in both WT and KO mice, specifically at later time points (14 and 27
days post-I/R). However, the increase in ESV in mice lacking OPN started at 3 days
post-I/R, while increase in ESV in WT mice was observed 7 days post-I/R. Interestingly,
both ESV and EDV were significantly higher in mice lacking OPN 3 days post-I/R. In a
non-reperfused MI model, lack of OPN has been shown to associate with increased LV
dilation and lower fibrosis 28 days post-MI17. The data presented here showed no
difference in ESV and EDV between the WT and KO mice 27 days post-I/R. These data
point towards the possibility that chamber dilation may be affected differently between
the non-perfused (MI) and reperfused (I/R) models. Deposition of fibrosis following an
injury affects heart function and remodeling processes. Therefore, analyses of
components of fibrosis post-I/R may help explain lack of excessive LV dilation in mice
lacking OPN 27 days post-I/R. However, early increase in ESV, and a significant
increase in ESV and EDV together with decreased %FS and %EF in mice lacking OPN
3 days post-I/R support the notion that lack of OPN decreases systolic functional
parameters of the heart following I/R injury.
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Diastolic dysfunction is commonly represented by changes in IVRT and E/A
wave ratio. Due to higher heart rates in mice (500 -700 beats/min), the E/A wave are
usually merged on pulse wave Doppler images and making it difficult to draw
conclusion. Therefore, this study did not analyze changes in E/A wave ratio. However,
we were able to assess other functional parameters of the heart such as AET and TST
using pulsed-wave Doppler images. Previous work from our lab has shown that IVRT is
not significantly different between the WT and OPN-KO mice at basal levels or 30 days
following induction of diabetes using streptozotocin21. However, this study did not
measure AET or TST. Acute MI patients are suggested to display a significant decrease
in AET and TST when compared to the normal patients22. Patients with dilated ischemic
heart disease also exhibit shorter IVRT23. Consistent with the streptozotocin study, IVRT
remained unchanged between WT and KO mice at basal levels. However, our study
revealed that I/R injury increases IVRT in WT mice 1 day post-MI. In contrast, no such
increase in IVRT was observed in mice lacking OPN. In fact, IVRT was significantly
lower in mice lacking OPN when compared to WT mice 1 day post-I/R. AET was
significantly shorter in mice lacking OPN when compared to WT mice at 3 and 27 days
post-I/R, while TST was also significantly shorter in mice lacking OPN when compared
to WT mice 3 days post-I/R. These findings suggest that lack of OPN decreases IVRT,
AET and TST, although at different time points, following a myocardial I/R injury.
The Vcf is an index of myocardial performance calculated from FS and AET.
Patients with myocardial disease are shown to exhibit lower mean Vcf when compared
with the normal subjects24. In this study, the Vcf was significantly higher in mice lacking
OPN at basal levels. While there was no significant difference in Vcf levels between KO
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and WT mice throughout the time course post-I/R, there was a significant decrease in
Vcf 1 day post-I/R in mice lacking OPN and remained lower in this group versus
baseline throughout the observation period. In WT mice, Vcf decreased significantly 1
day post-I/R when compared to baseline. It remained unchanged (vs baseline) at 3, 7
and 14 days post-I/R. These data further suggests that lack of OPN affects myocardial
contractility following I/R injury.
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Conclusion
Heart disease is a leading cause of death worldwide, affecting thousands of
individuals every year. More than half of these deaths are attributed to coronary artery
disease, which causes a buildup of plaque along the walls of arteries, and can lead to
an ischemia/reperfusion injury, or a heart attack. Myocardial I/R injuries are often linked
to heart failure. This study investigated the role of OPN in systolic and diastolic heart
function following an I/R injury. The major findings of this study were that lack of OPN
decreases %FS, %EF, AET, IVRT and TST compared to WT mice post-I/R, increases
ESV and EDV versus WT mice post-I/R, and increases Vcf versus WT mice at basal
levels. Collectively, the data presented here provide evidence that lack of OPN
exaggerates systolic and diastolic functional parameters of the heart following a
myocardial I/R injury. However, further investigations are needed to understand the
remodeling processes of the heart during OPN deficiency as OPN is described as a
multifunctional protein with a potential to affect myocardial inflammation, apoptosis,
hypertrophy, fibrosis etc. Understanding the role of OPN in heart function following an
I/R injury may support the perspective of OPN as a possible target for therapeutic
intervention in protection of the heart following a myocardial I/R injury.

30

Funding
This work is supported by Biomedical Laboratory Research and Development Service of
the Veterans Affairs Office of Research and Development Merit Review Award
BX004045, NIH NHLBI Grant R15HL141947 and funds from the Institutional Research
and Improvement account (to K. Singh).

31

References
1. Centers for Disease Control and Prevention. Heart Disease.
https://www.cdc.gov/heartdisease/index.htm. Published 2020.
2. Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected
therapeutic target. J Clin Invest. 2013;123(1):92-100.
3. Neri M, Riezzo I, Pascale N, Pomara C, Turillazzi E. Ischemia/reperfusion injury
following acute myocardial infarction: a critical issue for clinicians and
forensic pathologists. Mediators Inflamm. 2017;2017:1-14.
4. Kubin AM, Skoumal R, Tavi P, Kónyi A, Perjés A, Leskinen H, Ruskoaho
H, Szokodi I. Role of reactive oxygen species in the regulation of cardiac
contractility. J Mol Cell Cardiol. 2011 May;50(5):884-93.
5. Singh M, Dalal S, Singh K. Osteopontin: At the cross-roads of myocyte survival
and myocardial function. Life Sci. 2014 Nov 18;118(1):1-6.
6. Centers for Disease Control and Prevention. Coronary Artery Disease.
https://www.cdc.gov/heartdisease/coronary_ad.htm. Published 2019.
7. Medical University of Vienna. Left ventricular function.
https://www.123sonography.com/left-ventricular-function.
8. American Heart Association. Ejection Fraction Heart Failure Measurement.
https://www.heart.org/en/health-topics/heart-failure/diagnosing-heartfailure/ejection-fraction-heart-failure-measurement. Published 2017.
9. Klabunde R. Cardiovascular Physiology Concepts. Regulation of Stroke Volume.
https://www.cvphysiology.com/Cardiac%20Function/CF002. Published
2015.

32

10. Gillebert TC, Van de Veire N, De Buyzere ML, De Sutter J. Time intervals and
global cardiac function. Use and limitations. Eur Heart J. 2004
Dec;25(24):2185-6.
11. Bloch KE, Jugoon S, Sackner MA. Inductance cardiography
(thoracocardiography): a novel, noninvasive technique for monitoring left
ventricular filling. J Crit Care. 1999 Dec;14(4):177-85.
12. Gao S, Ho D, Vatner D, Vatner S. Echocardiography in Mice. Curr Protoc Mouse
Biol. 2011 Mar 1;1:71-83.
13. Singh M, Ananthula S, Milhorn DM, Krishnaswamy G, Singh K. Osteopontin: a
novel inflammatory mediator of cardiovascular disease. Front Biosci. 2007
Jan 1;12:214-21.
14. Dalal S, Qinqin Z, Daniels C, et al. Osteopontin stimulates apoptosis in adult
cardiac myocytes via the involvement of CD44 receptors, mitochondrial
death pathway, and endoplasmic reticulum stress. Am J Physiol Heart
Circ Physiol. 2014 Apr 15;306(8):H1182-H1191.
15. Singh M, Foster C, Dalal S, Singh K. Osteopontin: role in extracellular matrix
deposition and myocardial remodeling post-MI. J Mol Cell Cardiol. 2010
Mar;48(3):538-543.
16. Singh K, Sirokman G, Communal C, et al. Myocardial osteopontin expression
coincides with the development of heart failure. Hypertension. 1999
Feb;33(2):663-70.
17. Trueblood NA, Xie Z, Communal C, et al. Exaggerated left ventricular dilation
and reduced collagen deposition after myocardial infarction in mice lacking

33

osteopontin. Circ Res. 2001 May 25;88(10):1080-7.
18. Duerr GD, Mesenholl B, Heinemann JC, et al. Cardioprotective effects of
osteopontin-1 during development of murine ischemic cardiomyopathy.
Biomed Res Int. 2014;2014:124063.
19. Thrasher PR, Scofield SLC, Dalal S, Crawford CC, Singh M, Singh K. Ataxia
telangiectasia mutated kinase deficiency impairs the autophagic response
early during myocardial infarction. Am J Physiol Heart Circ Physiol. 2018
Jul 1;315(1):H48-H57.
20. Krishnamurthy P, Peterson JT, Subramanian V, Singh M, Singh K. Inhibition of
matrix metalloproteinases improves left ventricular function in mice lacking
osteopontin after myocardial infarction. Mol Cell Biochem. 2009
Feb;322(1-2):53-62.
21. Subramanian V, Krishnamurthy P, Singh K, Singh M. Lack of osteopontin
improves cardiac function in streptozotocin-induced diabetic mice. Am J
Physiol Heart Circ Physiol. 2007 Jan;292(1):H673-83.
22. Hodges M, Halpern BL, Friesinger GC, Dagenais GR. Left ventricular preejection
period and ejection time in patients with acute myocardial infarction.
Circulation. 1972 May;45(5):933-42.
23. Brecker SJD, Lee CH, Gibson DG. Relation of left ventricular isovolumic
relaxation time and incoordination to transmitral Doppler filling patterns. Br
Heart J. 1992;68:567-73.
24. Karliner JS, Gault JH, et al. Mean Velocity of Fiber Shortening: A Simplified
Measure of Left Ventricular Myocardial Contractility. Circulation.

34

1971;44:323-333.

35

